Frankfurt - Delayed Quote EUR

ChemoMetec A/S (CHY.F)

Compare
61.65
-3.10
(-4.79%)
As of 8:06:05 AM GMT+2. Market Open.
Loading Chart for CHY.F
  • Previous Close 64.75
  • Open 61.65
  • Bid 57.75 x --
  • Ask 58.40 x --
  • Day's Range 61.65 - 61.65
  • 52 Week Range 37.56 - 82.60
  • Volume 3
  • Avg. Volume 0
  • Market Cap (intraday) 1.073B
  • Beta (5Y Monthly) 1.60
  • PE Ratio (TTM) 47.42
  • EPS (TTM) 1.30
  • Earnings Date May 7, 2025
  • Forward Dividend & Yield 0.54 (0.83%)
  • Ex-Dividend Date Oct 11, 2024
  • 1y Target Est --

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops as well as develops XcytoMatic 30 cell counter. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.

chemometec.com

184

Full Time Employees

June 30

Fiscal Year Ends

Recent News: CHY.F

View More

Performance Overview: CHY.F

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .

YTD Return

CHY.F
8.46%
OMX Copenhagen 25 Index (^OMXC25)
13.77%

1-Year Return

CHY.F
31.65%
OMX Copenhagen 25 Index (^OMXC25)
20.67%

3-Year Return

CHY.F
33.79%
OMX Copenhagen 25 Index (^OMXC25)
14.36%

5-Year Return

CHY.F
156.28%
OMX Copenhagen 25 Index (^OMXC25)
35.69%

Compare To: CHY.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CHY.F

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    1.08B

  • Enterprise Value

    1.05B

  • Trailing P/E

    49.71

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    18.29

  • Price/Book (mrq)

    14.06

  • Enterprise Value/Revenue

    17.03

  • Enterprise Value/EBITDA

    33.02

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    36.79%

  • Return on Assets (ttm)

    19.86%

  • Return on Equity (ttm)

    30.83%

  • Revenue (ttm)

    459.54M

  • Net Income Avi to Common (ttm)

    169.08M

  • Diluted EPS (ttm)

    1.30

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    264.74M

  • Total Debt/Equity (mrq)

    1.30%

  • Levered Free Cash Flow (ttm)

    98.11M

Research Analysis: CHY.F

View More

Company Insights: CHY.F

Research Reports: CHY.F

View More

People Also Watch